Cardinal Health (CAH) Price to Sales (2009 - 2026)

Cardinal Health has disclosed Price to Sales across 18 years of filings, most recently posting 0.87 for Q2 2026.

• In Q2 2026, Price to Sales rose 30.12% year-over-year to 0.87; the TTM figure through Jun 2026 stood at 0.22 (up 20.57% YoY), while the FY2026 annual figure was 0.22, up 20.57% from the prior year.
• Price to Sales came in at 0.87 for Q2 2026 at Cardinal Health, up from 0.81 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 0.87 in Q2 2026 to a low of 0.3 in Q2 2022.
• Average Price to Sales over 5 years is 0.51, with a median of 0.47 recorded in 2023.
• Year-over-year, Price to Sales retreated 23.24% in 2022 and soared 66.52% in 2025.
• Over 5 years, Price to Sales stood at 0.38 in 2022, then increased by 10.92% to 0.43 in 2023, then rose by 21.12% to 0.52 in 2024, then surged by 42.53% to 0.74 in 2025, then gained by 17.76% to 0.87 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 0.87 in Q2 2026, 0.81 in Q1 2026, and 0.74 in Q4 2025.